Calamos Advisors’s CareDx CDNA Stock Holding History

Calamos Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-143,989	Closed	-$2.56M	–	934
2025 Q1	$2.56M	Buy	143,989 +56,724	+65%	+$1.22M	0.01%	571
2024 Q4	$1.87M	Sell	87,265 -36,137	-29%	-$879K	0.01%	612
2024 Q3	$3.85M	Buy	+123,402	New	+$3.07M	0.02%	552
2021 Q4	–	Sell	-35,134	Closed	-$2.23M	–	1126
2021 Q3	$2.23M	Sell	35,134 -40,634	-54%	-$3.09M	0.01%	765
2021 Q2	$6.93M	Buy	75,768 +30,448	+67%	+$2.42M	0.03%	494
2021 Q1	$3.09M	Sell	45,320 -477	-1%	-$37K	0.02%	630
2020 Q4	$3.32M	Buy	45,797 +2,312	+5%	+$134K	0.02%	563
2020 Q3	$1.65M	Buy	+43,485	New	+$1.47M	0.01%	613
2019 Q4	–	Sell	-111,133	Closed	-$2.51M	–	776
2019 Q3	$2.51M	Sell	111,133 -61,371	-36%	-$1.7M	0.01%	595
2019 Q2	$6.21M	Buy	+172,504	New	+$5.52M	0.03%	462

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Calamos Advisors's CDNA Position: Q2 2025 in Review

Calamos Advisors sold out of CareDx (CDNA) in Q2 2025, closing a stake of 143,989 shares — an estimated $2.56M sold.

Calamos Advisors first reported a position in CDNA in Q2 2019 and held it in 10 quarters. The position peaked at $6.93M in Q2 2021. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

Calamos Advisors reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
Calamos Advisors sold 143,989 CareDx shares in Q2 2025, an estimated $2.56M.
Calamos Advisors first reported a position in CareDx in Q2 2019 and held it in 10 quarters.
Calamos Advisors's CareDx position peaked at $6.93M in Q2 2021.
197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Calamos Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.